• NCCNde Kategori 1 Seviyesinde nerilen FDA Onayl Meme Kanseri Nks
    NCCN'de Kategori 1 Seviyesinde
  • 19Mays Atatrk Anma Genlik ve Spor Bayrammzn 100yl kutlu olsun
    19.Mayıs Atatürk'ü Anma Gençlik
  • 17 Nisan Dnya Kanser Haftas Kansere deil hayata ans verin
    1-7 Nisan Dünya Kanser
  • Saygyla ve kranla anyoruz 18martanakkalezaferi
    Saygıyla ve şükranla anıyoruz..
  • 8 Mart Dnya Kadnlar Gnnz Kutlu Olsun dnyakadnlargn 8Mart mammaprint
    8 Mart Dünya Kadınlar
  • 2Genlerle Onkolojiye Bak Kongresi 1417 Subat 2019 mammaprint blueprint memekanseritedavisi
    2.Gençlerle Onkolojiye Bakış Kongresi,
  • MammaPrint Meme Kanseri Nks Testi iin nemli zel Salk Sigortalar
    MammaPrint Meme Kanseri Nüks
  • Erken Evre Meme Kanseri hastalarnn 46sna gereksiz yere kemoterapi verilmesini
    Erken Evre Meme Kanseri
  • Erken Evre Meme Kanseri hastalarnda kemoterapi kararnn verilmesi aamasnda klinik
    Erken Evre Meme Kanseri
  • Istanbul Bilim niversitesi 10Onkoloji Gnleri iin bata memeder Onursal Bakan
    Istanbul Bilim Üniversitesi 10.Onkoloji
  • Erken Evre Meme Kanseri hastalarnda kemoterapi verilip verilmemesi aamasnda kararsz
    Erken Evre Meme Kanseri
  • Istanbul Bilim niversitesi 10Onkoloji Gnleri 2223 Aralk 2018 gereksizkemoterapiyeson kategori1seviyesi
    Istanbul Bilim Üniversitesi 10.Onkoloji


The goal of MammaPrint test is determine which breast cancer patients confirmed with chemotherapy and which patients do not need a chemotherapy treatment by examining closer genetic of tumor on.


BluePrint functional molecular subtyping classifies breast cancer into three different subtypes which long-term result in each and with significans differences to answer neoadjuan chemotherapy Luminal-type (A or B), Basal-type, or HER2-type.


While talking about cancer, interpreting without “genetic” is impossible because of mutation is the reason of cancer. Determining cancers that having genetic risk on early stage is possible through new genetic tests.

BRCA 1/2

If a woman carries a dangerous mutation in genes of BRCA1 and BRCA2, risk of breast and / or ovarian cancer development is increase on a large scale entire whole life.

Your tumor is UNIQUE, your TREATMENT should be too.

Frequently Asked Questions
What is the genetic test?



Did you know that every early grade breast cancer patient does not need a chemotherapy treatment?

The Genetics of Cancer

What is the genomic test?

About Genomic Tests

Recent Posts

API –>